BCG vaccination in South African HIV-exposed infants – risks and benefits

類似資料

• Disseminated bacille Calmette–Guérin disease in HIV-infected South African infants
  著者:: Hesseling, AC, 等
  出版事項: (2009)
• Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination
  著者:: Hesseling, A. C., 等
  出版事項: (2015)
• T Cell Activation in South African HIV-Exposed Infants Correlates with Ochratoxin A Exposure
  著者:: Lianna Frances Wood, 等
  出版事項: (2017-12-01)
• BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial
  著者:: Gasper, Melanie A., 等
  出版事項: (2017)
• Delaying BCG Vaccination Until 8 Weeks of Age Results in Robust BCG-Specific T-Cell Responses in HIV-Exposed Infants
  著者:: Tchakoute, Christophe Toukam, 等
  出版事項: (2015)